United Therapeutics reports loss in 4Q

United Therapeutics Corp., of Silver Spring, saw its bottom line plunge in 2013’s fourth quarter, reporting a net loss of $30.3 million, or 60 cents per diluted share, versus net income of $83.25 million, or $1.60 per diluted share, for the year-before period.

Leave a Reply

Your email address will not be published. Required fields are marked *